Prenetics raises USD10 mn investment led by China's Ping An
16-Mar-16, Yahoo
Prenetics, a precision medicine life sciences company focused on personalized, predictive and preventive treatments announced a US$10 Million Series A strategic investment led by Ping An Ventures, the venture capital arm of Ping An Insurance Group, one of the largest insurance companies in China.
Other investors include Indonesia's Lippo Group backed Venturra Capital, Capital Union Investments and existing investors 500 Startups, COENT Venture Partners.
%20Prenetics.jpg "Prenetics raises USD10 mn investment led by Chinas Ping An (c) Prenetics")
Image: Prenetics
Prenetics' proprietary iGenes test helps physicians prescribe medications and dosages to achieve the most effective results with the least side effects, based on a patient's unique genetic profile.
Ping An Ventures Managing Director Jiang Zhang stated, "We believe precision medicine is the future of healthcare, primed to happen now. Prenetics has built an amazing team with a world-class scientific, medical and commercial team. We are excited to integrate Prenetics innovative DNA tests to help our 200 million customers live longer, healthier lives while saving substantial healthcare costs."